Oncology Nurse Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians ...

Relative survival increased from 64% to 66%, overall survival from 54% to 55%, and lymphoma-specific survival from 64% to 66%.

Researchers examined patient-reported outcomes for quality of life following Mohs micrographic surgery for facial skin cancer.

Researchers found a significant tradeoff between harms and benefits for patients who received an ICI plus chemotherapy in the first-line setting.

Using data from the Global Burden of Disease 2021 database, researchers identified specific etiologies and other factors contributing to the burden of primary liver cancer in patients across the ...

A literature review explored the omics-based approach to symptom biomarker identification to determine how these biomarkers affect symptom management strategies.

HealthDay News — Different measurement tools and diagnostic criteria show low-to-moderate agreement for diagnosing breast cancer-related lymphedema (BCRL), according to a study published in the April ...

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.

Five-year data from the KEYNOTE-048 trial support the use of pembrolizumab and pembrolizumab-chemotherapy as standards of care, researchers wrote.

Researchers found that C-reactive protein is a biomarker for psychological stress in caregivers of patients with primary malignant brain tumor.

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

Researchers conducted a retrospective cohort study to assess the incidence of lymph node metastases among patients with papillary thyroid cancer.